DIANNE DAVID: Open Payments
NPI 1285149229 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,699 in 116 payments from 25 companies in 2025. Trend: 2023 $2,402 · 2024 $3,583 · 2025 $2,699
Food & beverage: $2,699
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $292 |
| Novartis Pharmaceuticals Corporation | 12 | $246 |
| UCB, Inc. | 9 | $243 |
| Mallinckrodt Hospital Products Inc. | 5 | $191 |
| PFIZER INC. | 11 | $183 |
| Eisai Inc. | 6 | $179 |
| Vanda Pharmaceuticals Inc. | 8 | $178 |
| SK Life Science, Inc. | 5 | $155 |
| Otsuka America Pharmaceutical, Inc. | 7 | $155 |
| EMD Serono, Inc. | 7 | $139 |
Products named: KESIMPTA, LEQEMBI, ACTHAR, NURTEC ODT, PONVORY, QULIPTA, REXULTI, UBRELVY.
Industry payments across FL — which companies pay providers there.
